<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nadeu F</submitter><funding>European Hematology Association</funding><funding>NCI NIH HHS</funding><pagination>1419-1432</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7498364</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>136(12)</volume><pubmed_abstract>Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1 rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL), that differ in their clinicobiological behavior. To identify the genetic and epigenetic alterations determining this diversity, we used whole-genome (n = 61) and exome (n = 21) sequencing (74% cMCL, 26% nnMCL) combined with transcriptome and DNA methylation profiles in the context of 5 MCL reference epigenomes. We identified that open and active chromatin at the major translocation cluster locus might facilitate the t(11;14)(q13;32), which modifies the 3-dimensional structure of the involved regions. This translocation is mainly acquired in precursor B cells mediated by recombination-activating genes in both MC</pubmed_abstract><journal>Blood</journal><pubmed_title>Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.</pubmed_title><pmcid>PMC7498364</pmcid><funding_grant_id>RG5</funding_grant_id><funding_grant_id>P01 CA229100</funding_grant_id><pubmed_authors>Bea S</pubmed_authors><pubmed_authors>Kulis M</pubmed_authors><pubmed_authors>Siebert R</pubmed_authors><pubmed_authors>Chapaprieta V</pubmed_authors><pubmed_authors>Torrents D</pubmed_authors><pubmed_authors>Diaz-Navarro A</pubmed_authors><pubmed_authors>Colomer D</pubmed_authors><pubmed_authors>Puiggros M</pubmed_authors><pubmed_authors>Aymerich M</pubmed_authors><pubmed_authors>Costa D</pubmed_authors><pubmed_authors>Castellano G</pubmed_authors><pubmed_authors>Jares P</pubmed_authors><pubmed_authors>Valdes-Mas R</pubmed_authors><pubmed_authors>Duran-Ferrer M</pubmed_authors><pubmed_authors>Martin-Subero JI</pubmed_authors><pubmed_authors>Vilarrasa-Blasi R</pubmed_authors><pubmed_authors>Lopez C</pubmed_authors><pubmed_authors>Nadeu F</pubmed_authors><pubmed_authors>Puente XS</pubmed_authors><pubmed_authors>Kuppers R</pubmed_authors><pubmed_authors>Navarro A</pubmed_authors><pubmed_authors>Muntanola A</pubmed_authors><pubmed_authors>Espinet B</pubmed_authors><pubmed_authors>Royo R</pubmed_authors><pubmed_authors>Gutierrez-Abril J</pubmed_authors><pubmed_authors>Clot G</pubmed_authors><pubmed_authors>Campo E</pubmed_authors><pubmed_authors>Ribera-Cortada I</pubmed_authors><pubmed_authors>Martin-Garcia D</pubmed_authors><pubmed_authors>Lopez-Guillermo A</pubmed_authors><pubmed_authors>Gine E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.</name><description>Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1 rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL), that differ in their clinicobiological behavior. To identify the genetic and epigenetic alterations determining this diversity, we used whole-genome (n = 61) and exome (n = 21) sequencing (74% cMCL, 26% nnMCL) combined with transcriptome and DNA methylation profiles in the context of 5 MCL reference epigenomes. We identified that open and active chromatin at the major translocation cluster locus might facilitate the t(11;14)(q13;32), which modifies the 3-dimensional structure of the involved regions. This translocation is mainly acquired in precursor B cells mediated by recombination-activating genes in both MC</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2026-05-02T15:02:28.198Z</modification><creation>2020-09-30T07:03:48Z</creation></dates><accession>S-EPMC7498364</accession><cross_references><pubmed>32584970</pubmed><doi>10.1182/blood.2020005289</doi></cross_references></HashMap>